Replies to post #130785 on Cytodyn Inc (CYDY)

[moneycrew]

FYI..even with flu vaccines, Tamiflu is 18 billion a year

[Chuckles759]

HH, I see the vaccines reducing the numbers of long haulers because it will reduce the number of severe to critical COVID cases, but I'm almost certain that there will still be vaccine recipients who will become long haulers...even the ones who deal with a M/M case.

[Blane]

No. There is no evidence that fewer people will get Covid. Additionally, the CMO of Moderna clearly stated that was not a reasonable assumption.

https://www.businessinsider.com/moderna-chief-medical-officer-vaccines-interview-2020-11
“Moderna's chief medical officer says that vaccine trial results only show that they prevent people from getting sick — not necessarily that recipients won't still be able to transmit the virus”


Another item to note is that Cytodyn is first in line for severe/critical data for mortality. AND if Leronlimab’s data shows a statistically significant cut in mortality, it will prove Leronlimab’s use in immune modulating and inflammatory conditions (I’m sure someone else can help name the numerous indications that involves).

One of the first vaccines in the race is an IV infusion. Good luck with that. The second has people demonstrating horrible side effects after the second shot, so it would be understood why some would rather risk getting Covid, getting natural immunity with it, and NOT injecting unknown substances in their bodies.

Vaccine? If it prevented transmission, maybe. But the current vaccines are just another flu shot in terms of MOA. And many people I speak to don’t realize it doesn’t prevent infectiousness.

Try again.

[Bobbythebus]

Vaccines won’t be avail to the public till may at the least .

[misiu143]

Humble Howard , I am trying to catch up with the board , and I like to make a comments about your post ..

I believe that our study for long haulers opening many big doors for us , for a giant possibilities .

If results will be positive , and they should be , it will open a door for us in many other possibilities , all post viral diseases , and after other germs like with Lyme disease , etc ..

This is giant , fibromyalgia , chronic fatigue syndrome , mononucleosis , and many , many other when some patients suffering for years .,

We for now the only one doing studies here , but many companies will try soon , it is a very big market ,

I really think that we have a very good shot with it ...

And it will be giant ..

GLTU

All imo...